Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Shares Outstanding (Diluted Average): 2020-2023

Historic Shares Outstanding (Diluted Average) for Pharming Group N.V (PHAR) over the last 3 years, with Dec 2023 value amounting to $724.1 million.

  • Pharming Group N.V's Shares Outstanding (Diluted Average) rose 19.51% to $785.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $785.5 million, marking a year-over-year increase of 19.51%. This contributed to the annual value of $724.1 million for FY2023, which is N/A change from last year.
  • Pharming Group N.V's Shares Outstanding (Diluted Average) amounted to $724.1 million in FY2023, which was down 19.72% from $901.9 million recorded in FY2021.
  • Pharming Group N.V's Shares Outstanding (Diluted Average)'s 5-year high stood at $901.9 million during FY2021, with a 5-year trough of $724.1 million in FY2023.
  • In the last 2 years, Pharming Group N.V's Shares Outstanding (Diluted Average) had a median value of $813.0 million in 2021 and averaged $813.0 million.
  • Data for Pharming Group N.V's Shares Outstanding (Diluted Average) shows a peak YoY climbed of 6.99% (in 2021) over the last 5 years.
  • Over the past 3 years, Pharming Group N.V's Shares Outstanding (Diluted Average) (Yearly) stood at $842.9 million in 2020, then climbed by 6.99% to $901.9 million in 2021, then reached $724.1 million in 2023.